Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Two cases of opercular myoclonic-anarthric status epilepticus.

Muñoz-Lopetegi A, Fernández García de Eulate G, Rodríguez-Antigüedad Muñoz J, Bergareche A, José Poza J.

Epileptic Disord. 2018 Jun 1;20(3):189-194. doi: 10.1684/epd.2018.0973.

PMID:
29905156
2.

Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease.

Ruiz-Martínez J, Azcona LJ, Bergareche A, Martí-Massó JF, Paisán-Ruiz C.

Neurol Genet. 2017 Aug 2;3(5):e177. doi: 10.1212/NXG.0000000000000177. eCollection 2017 Oct.

3.

Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.

Delgado-Alvarado M, Gago B, Gorostidi A, Jiménez-Urbieta H, Dacosta-Aguayo R, Navalpotro-Gómez I, Ruiz-Martínez J, Bergareche A, Martí-Massó JF, Martínez-Lage P, Izagirre A, Rodríguez-Oroz MC.

Mov Disord. 2017 Jul;32(7):1066-1073. doi: 10.1002/mds.27001. Epub 2017 May 26.

PMID:
28548309
4.

Nontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.

de la Riva P, Zubikarai M, Sarasqueta C, Tainta M, Muñoz-Lopetegui A, Andrés-Marín N, González F, Díez N, de Arce A, Bergareche A, Lopez de Munain A, Martínez-Zabaleta M.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1670-1677. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.024. Epub 2017 Apr 13.

PMID:
28412318
5.

A protective personal factor against disability and dependence in the elderly: an ordinal regression analysis with nine geographically-defined samples from Spain.

Virues-Ortega J, Vega S, Seijo-Martinez M, Saz P, Rodriguez F, Rodriguez-Laso A, de Las Heras SP, Mateos R, Martinez-Martin P, Mahillo-Fernandez I, Garre-Olmo J, Gascon J, Garcia-Garcia FJ, Fernandez-Martinez M, Bermejo-Pareja F, Bergareche A, Benito-Leon J, de Pedro-Cuesta J; Spanish Epidemiological Studies on Ageing Group.

BMC Geriatr. 2017 Jan 31;17(1):42. doi: 10.1186/s12877-016-0409-9.

6.

Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.

Gorostidi A, Martí-Massó JF, Bergareche A, Rodríguez-Oroz MC, López de Munain A, Ruiz-Martínez J.

Mol Diagn Ther. 2016 Oct;20(5):481-91. doi: 10.1007/s40291-016-0216-1.

PMID:
27294386
7.

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.

Bergareche A, Rodríguez-Oroz MC, Estanga A, Gorostidi A, López de Munain A, Castillo-Triviño T, Ruiz-Martínez J, Mondragón E, Gaig C, Lomeña F, Sarasqueta C, Tolosa E, Martí-Massó JF.

Mov Disord. 2016 Mar;31(3):335-43. doi: 10.1002/mds.26478. Epub 2015 Dec 21.

PMID:
26686514
8.

SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy.

Bergareche A, Bednarz M, Sánchez E, Krebs CE, Ruiz-Martinez J, De La Riva P, Makarov V, Gorostidi A, Jurkat-Rott K, Marti-Masso JF, Paisán-Ruiz C.

Hum Mol Genet. 2015 Dec 15;24(24):7111-20. doi: 10.1093/hmg/ddv410. Epub 2015 Oct 1.

9.

Parkinson's Disease Case Ascertainment in the EPIC Cohort: The NeuroEPIC4PD Study.

Gallo V, Brayne C, Forsgren L, Barker RA, Petersson J, Hansson O, Lindqvist D, Ruffmann C, Ishihara L, Luben R, Arriola L, Bergareche A, Gavrila D, Erro ME, Vanacore N, Sacerdote C, Bueno-de-Mesquita B, Vermeulen R, Seelen M, Sieri S, Masala G, Ramat S, Kyrozis A, Thricopolou A, Panico S, Mattiello A, Kaaks R, Teucher B, Katzke V, Kloss M, Curry L, Calboli F, Riboli E, Vineis P, Middleton L.

Neurodegener Dis. 2015;15(6):331-8. doi: 10.1159/000381857. Epub 2015 Sep 17.

PMID:
26375921
10.

SORT1 Mutation Resulting in Sortilin Deficiency and p75(NTR) Upregulation in a Family With Essential Tremor.

Sánchez E, Bergareche A, Krebs CE, Gorostidi A, Makarov V, Ruiz-Martinez J, Chorny A, Lopez de Munain A, Marti-Masso JF, Paisán-Ruiz C.

ASN Neuro. 2015 Aug 21;7(4). pii: 1759091415598290. doi: 10.1177/1759091415598290. Print 2015 Jul-Aug.

11.

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.

Estanga A, Rodriguez-Oroz MC, Ruiz-Martinez J, Barandiaran M, Gorostidi A, Bergareche A, Mondragon E, Lopez de Munain A, Marti-Masso JF.

Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.

PMID:
25127457
12.

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

Ruiz-Martínez J, de la Riva P, Rodríguez-Oroz MC, Mondragón Rezola E, Bergareche A, Gorostidi A, Gago B, Estanga A, Larrañaga N, Sarasqueta C, López de Munain A, Martí Massó JF.

Mov Disord. 2014 May;29(6):750-5. doi: 10.1002/mds.25778. Epub 2013 Dec 19.

PMID:
24357540
13.

Lewy bodies under atomic force microscope.

Tercjak A, Bergareche A, Caballero C, Tuñon T, Linazasoro G.

Ultrastruct Pathol. 2014 Feb;38(1):1-5. doi: 10.3109/01913123.2013.825689. Epub 2013 Oct 17.

PMID:
24134525
14.

The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism.

Martí-Massó JF, Bergareche A, Makarov V, Ruiz-Martinez J, Gorostidi A, López de Munain A, Poza JJ, Striano P, Buxbaum JD, Paisán-Ruiz C.

J Mol Med (Berl). 2013 Dec;91(12):1399-406. doi: 10.1007/s00109-013-1075-4. Epub 2013 Aug 20.

15.

Αlpha-synuclein levels in blood plasma from LRRK2 mutation carriers.

Gorostidi A, Bergareche A, Ruiz-Martínez J, Martí-Massó JF, Cruz M, Varghese S, Qureshi MM, Alzahmi F, Al-Hayani A, López de Munáin A, El-Agnaf OM.

PLoS One. 2012;7(12):e52312. doi: 10.1371/journal.pone.0052312. Epub 2012 Dec 27.

16.

Medical, environmental and personal factors of disability in the elderly in Spain: a screening survey based on the International Classification of Functioning.

Virués-Ortega J, de Pedro-Cuesta J, del Barrio JL, Almazan-Isla J, Bergareche A, Bermejo-Pareja F, Fernández-Mayoralas G, García FJ, Garre-Olmo J, Gascon-Bayarri J, Mahillo I, Martínez-Martín P, Mateos R, Rodríguez F, Rojo-Pérez F, Avellanal F, Saz P, Seijo-Martínez M; Spanish Epidemiological Study Group on Aging.

Gac Sanit. 2011 Dec;25 Suppl 2:29-38. doi: 10.1016/j.gaceta.2011.07.021. Epub 2011 Nov 15.

17.

Sleep disorders in Parkinson disease.

Iranzo de Riquer A, Bergareche A, Campos V.

Neurologist. 2011 Nov;17(6 Suppl 1):S38-42. doi: 10.1097/NRL.0b013e31823966f8. Review.

PMID:
22045324
18.

Exome sequencing identifies GCDH (glutaryl-CoA dehydrogenase) mutations as a cause of a progressive form of early-onset generalized dystonia.

Marti-Masso JF, Ruiz-Martínez J, Makarov V, López de Munain A, Gorostidi A, Bergareche A, Yoon S, Buxbaum JD, Paisán-Ruiz C.

Hum Genet. 2012 Mar;131(3):435-42. doi: 10.1007/s00439-011-1086-6. Epub 2011 Sep 13.

PMID:
21912879
19.

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Ruiz-Martínez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodríguez F, Bergareche A, Moreno F, López de Munain A, Martí Massó JF.

Mov Disord. 2011 Sep;26(11):2026-31. doi: 10.1002/mds.23773. Epub 2011 May 24.

PMID:
21611983
20.

Prevalence of disability in a composite ≥75 year-old population in Spain: a screening survey based on the International Classification of Functioning.

Virués-Ortega J, de Pedro-Cuesta J, Seijo-Martínez M, Saz P, Sánchez-Sánchez F, Rojo-Pérez F, Rodríguez F, Mateos R, Martínez-Martín P, Mahillo I, Gascon-Bayarri J, Garre-Olmo J, García FJ, Fernández-Mayoralas G, Bermejo-Pareja F, Bergareche A, Almazan-Isla J, del Barrio JL.

BMC Public Health. 2011 Mar 23;11:176. doi: 10.1186/1471-2458-11-176.

21.

[Parkinsonism induced by sulpiride and veralipride: two different stories].

Martí Massó JF, Ruiz-Martínez J, Bergareche A, López de Munain A.

Med Clin (Barc). 2011 Oct 15;137(10):473-4. doi: 10.1016/j.medcli.2010.09.038. Epub 2011 Feb 4. Spanish. No abstract available.

PMID:
21295788
22.

Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).

Ruiz-Martínez J, Gorostidi A, Ibañez B, Alzualde A, Otaegui D, Moreno F, López de Munain A, Bergareche A, Gómez-Esteban JC, Martí Massó JF.

Mov Disord. 2010 Oct 30;25(14):2340-5. doi: 10.1002/mds.23278.

PMID:
20721916
23.

Prevalence and European comparison of dementia in a ≥75-year-old composite population in Spain.

Virués-Ortega J, de Pedro-Cuesta J, Vega S, Seijo-Martínez M, Saz P, Rodríguez F, Rodríguez-Laso A, Reñé R, de Las Heras SP, Mateos R, Martínez-Martín P, Mahillo-Fernández I, López-Pousa S, Lobo A, Reglà JL, Gascón J, García FJ, Fernández-Martínez M, Boix R, Bermejo-Pareja F, Bergareche A, Sánchez-Sánchez F, de Arce A, del Barrio JL; Spanish Epidemiological Studies on Ageing Group.

Acta Neurol Scand. 2011 May;123(5):316-24. doi: 10.1111/j.1600-0404.2010.01398.x.

PMID:
20636450
24.

What contributes to driving ability in Parkinson's disease.

Cubo E, Martinez Martin P, Gonzalez M, Bergareche A, Campos V, Fernández JM, Alvárez M, Bayes A; Elep Group.

Disabil Rehabil. 2010;32(5):374-8. doi: 10.3109/09638280903168507.

PMID:
19958153
25.

"Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.

Moreno F, Indakoetxea B, Barandiaran M, Alzualde A, Gabilondo A, Estanga A, Ruiz J, Ruibal M, Bergareche A, Martí-Massó JF, López de Munain A.

Neurology. 2009 Oct 27;73(17):1367-74. doi: 10.1212/WNL.0b013e3181bd82a7.

PMID:
19858458
26.

Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008.

de Pedro-Cuesta J, Virués-Ortega J, Vega S, Seijo-Martínez M, Saz P, Rodríguez F, Rodríguez-Laso A, Reñé R, de las Heras SP, Mateos R, Martínez-Martín P, Manubens JM, Mahillo-Fernandez I, López-Pousa S, Lobo A, Reglà JL, Gascón J, García FJ, Fernández-Martínez M, Boix R, Bermejo-Pareja F, Bergareche A, Benito-León J, de Arce A, del Barrio JL.

BMC Neurol. 2009 Oct 19;9:55. doi: 10.1186/1471-2377-9-55.

27.

[Tremor: update and controversy].

Ruiz-Martínez J, Arratibel-Echarren I, Gorostidi-Pagola A, Bergareche A, Martí-Massó JF.

Rev Neurol. 2009 Jan 23;48 Suppl 1:S37-41. Review. Spanish.

28.

Wired for autonomy.

da Rocha AC, Bergareche AM.

Am J Bioeth. 2008 May;8(5):23-5; discussion W1-3. doi: 10.1080/15265160802180042. No abstract available.

PMID:
18642192
29.

Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.

López de Munain A, Alzualde A, Gorostidi A, Otaegui D, Ruiz-Martínez J, Indakoetxea B, Ferrer I, Pérez-Tur J, Sáenz A, Bergareche A, Barandiarán M, Poza JJ, Zabalza R, Ruiz I, Urtasun M, Fernández-Manchola I, Olasagasti B, Espinal JB, Olaskoaga J, Ruibal M, Moreno F, Carrera N, Martí Massó JF.

Biol Psychiatry. 2008 May 15;63(10):946-52. Epub 2007 Oct 22.

PMID:
17950702
30.

[Prevalence of vascular risk factors among Spanish populations aged 70 years and over, as reported in door-to-door studies on neurological diseases].

del Barrio JL, Medrano MJ, Arce A, Bergareche A, Bermejo F, Díaz J, Gascón J, García FJ, Garré J, Gómez C, Lobo A, Martínez A, Otero A, Reñé R, Sánchez MI, Saz P, Vega S, Vilalta-Franch J, Zunzunegui MV, de Pedro J.

Neurologia. 2007 Apr;22(3):138-46. Spanish.

PMID:
17364251
31.

[A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep].

Martínez-Martín P, Cubo-Delgado E, Aguilar-Barberà M, Bergareche A, Escalante S, Rojo A, Campdelacreu J, Frades-Payo B, Arroyo S; Grupo ELEP.

Rev Neurol. 2006 Nov 16-30;43(10):577-83. Spanish.

32.

Stroke prevalence among the Spanish elderly: an analysis based on screening surveys.

Boix R, del Barrio JL, Saz P, Reñé R, Manubens JM, Lobo A, Gascón J, de Arce A, Díaz-Guzmán J, Bergareche A, Bermejo-Pareja F, de Pedro-Cuesta J; Spanish Epidemiological Study Group on Ageing.

BMC Neurol. 2006 Oct 16;6:36.

33.

Early onset parkinsonism in dementia lacking distinct histopathological features.

Bergareche A, Martí-Massó JF, Linacasoro G, Arrinda JM, De Arce A.

Clin Neuropathol. 2006 Jan-Feb;25(1):14-7.

PMID:
16465769
34.

Dementia, stroke and Parkinson's disease in Spanish populations: a review of door-to-door prevalence surveys.

del Barrio JL, de Pedro-Cuesta J, Boix R, Acosta J, Bergareche A, Bermejo-Pareja F, Gabriel R, García de Yébenes MJ, García FJ, López-Pousa S, Manubens JM, Mateos R, Matías-Guiu J, Olivé JM, Reñé R, Rodríguez F, Saz P.

Neuroepidemiology. 2005;24(4):179-88. Epub 2005 Apr 12. Review.

35.

Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain.

Bergareche A, De La Puente E, López de Munain A, Sarasqueta C, de Arce A, Poza JJ, Martí-Massó JF.

J Neurol. 2004 Mar;251(3):340-5.

PMID:
15015016
36.

The validity of Hodkinson's Abbreviated Mental Test for dementia screening in Guipuzcoa, Spain.

Sarasqueta C, Bergareche A, Arce A, Lopez de Munain A, Poza JJ, De La Puente E, Urtasun M, Emparanza JE, Martí Masso JF.

Eur J Neurol. 2001 Sep;8(5):435-40.

PMID:
11554906
37.

Prevalence of essential tremor: a door-to-door survey in bidasoa, spain.

Bergareche A, De La Puente E, López De Munain A, Sarasqueta C, De Arce A, Poza JJ, Martí-Massó JF.

Neuroepidemiology. 2001 May;20(2):125-8.

PMID:
11359080
38.

Metabolism and the problem of its universalization.

Bergareche AM, Ruiz-Mirazo K.

Biosystems. 1999 Jan;49(1):45-61.

PMID:
10091972
39.

Structural limits for evolutive capacities in complex molecular systems.

Bergareche AM, Ostolaza JF.

Riv Biol. 1990;83(2-3):335-47.

PMID:
1707552

Supplemental Content

Loading ...
Support Center